Free Trial

InfuSystem (INFU) News Today

InfuSystem logo
$5.64 -0.47 (-7.69%)
Closing price 03/10/2025 04:00 PM Eastern
Extended Trading
$5.64 +0.00 (+0.02%)
As of 03/10/2025 04:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
InfuSystem (NYSE:INFU) Cut to Buy at StockNews.com
B. Riley Issues Negative Forecast for InfuSystem Earnings
InfuSystem Holdings, Inc. stock logo
B. Riley Has Negative Estimate for InfuSystem Q1 Earnings
InfuSystem Holdings, Inc. (NYSE:INFU - Free Report) - Equities researchers at B. Riley cut their Q1 2025 EPS estimates for InfuSystem in a research note issued to investors on Tuesday, March 4th. B. Riley analyst K. Bauser now anticipates that the company will post earnings of ($0.03) per share f
InfuSystem Holdings, Inc. stock logo
InfuSystem (NYSE:INFU) Downgraded to Buy Rating by StockNews.com
StockNews.com downgraded shares of InfuSystem from a "strong-buy" rating to a "buy" rating in a research note on Thursday.
InfuSystem Holdings, Inc. stock logo
B. Riley Comments on InfuSystem's Q2 Earnings (NYSE:INFU)
InfuSystem Holdings, Inc. (NYSE:INFU - Free Report) - Equities research analysts at B. Riley cut their Q2 2025 EPS estimates for InfuSystem in a note issued to investors on Tuesday, March 4th. B. Riley analyst K. Bauser now anticipates that the company will post earnings per share of $0.05 for th
InfuSystem Shares Drop After 4Q Earnings Miss
InfuSystem reports Q4 EPS 4c, consensus 6c
InfuSystem sees FY25 revenue growth 8%-10%, consensus $147.89M
InfuSystem Set For Strong Year
InfuSystem to Present at Sidoti Investor Conference
InfuSystem management to meet virtually with B. Riley
InfuSystem Holdings, Inc. stock logo
B. Riley Issues Pessimistic Forecast for InfuSystem Earnings
InfuSystem Holdings, Inc. (NYSE:INFU - Free Report) - Equities researchers at B. Riley decreased their FY2024 EPS estimates for shares of InfuSystem in a research report issued to clients and investors on Thursday, November 7th. B. Riley analyst K. Bauser now anticipates that the company will ear
InfuSystem Holdings, Inc. stock logo
InfuSystem (NYSE:INFU) Upgraded at StockNews.com
StockNews.com upgraded InfuSystem from a "buy" rating to a "strong-buy" rating in a research note on Friday.
Q3 2024 InfuSystem Holdings Inc Earnings Call
Craig-Hallum Sticks to Their Buy Rating for Lifecore Biomedical (LFCR)
InfuSystem Reports Third Quarter 2024 Financial Results
Inotiv (NOTV) Receives a Buy from Craig-Hallum
Craig-Hallum Remains a Buy on Ligand Pharma (LGND)
Craig-Hallum Remains a Buy on Schrodinger (SDGR)
Digital blood pressure monitor, glucometer, stethoscope, notepad and alarm clock on blue background top view — Photo
The Future of Medical Devices: Two Strong Buys You Can't Miss
Two medical device companies with strong buy ratings are positioned for growth in the growing healthcare devices market.
September 2024's UK Stock Picks For Possible Value Investing
InfuSystem Holdings, Inc. stock logo
StockNews.com Downgrades InfuSystem (NYSE:INFU) to Buy
StockNews.com downgraded shares of InfuSystem from a "strong-buy" rating to a "buy" rating in a report on Saturday.
InfuSystem Holdings, Inc. stock logo
Meros Investment Management LP Sells 164,113 Shares of InfuSystem Holdings, Inc. (NYSE:INFU)
Meros Investment Management LP reduced its holdings in shares of InfuSystem Holdings, Inc. (NYSE:INFU - Free Report) by 21.0% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 616,138 shares of the compa
InfuSystem Holdings, Inc. stock logo
InfuSystem (NYSE:INFU) Stock Rating Upgraded by B. Riley
B. Riley raised InfuSystem to a "strong-buy" rating in a research note on Wednesday.
Craig-Hallum Sticks to Its Buy Rating for Omnicell (OMCL)
Craig-Hallum Sticks to Its Buy Rating for Ligand Pharma (LGND)
InfuSystem Holdings, Inc. stock logo
InfuSystem (NYSE:INFU) Coverage Initiated by Analysts at B. Riley
B. Riley initiated coverage on shares of InfuSystem in a report on Thursday. They issued a "buy" rating and a $13.00 price objective for the company.
Craig-Hallum Remains a Buy on NeoGenomics (NEO)
Craig-Hallum Sticks to Their Buy Rating for Repligen (RGEN)
Craig-Hallum Keeps Their Buy Rating on InfuSystem Holdings, Inc. (INFU)
InfuSystem Set For Strong Second Half
Remove Ads
Get InfuSystem News Delivered to You Automatically

Sign up to receive the latest news and ratings for INFU and its competitors with MarketBeat's FREE daily newsletter.

INFU Media Mentions By Week

INFU Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

INFU
News Sentiment

-0.23

0.50

Average
Medical
News Sentiment

INFU News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

INFU Articles
This Week

19

1

INFU Articles
Average Week

Remove Ads
Get InfuSystem News Delivered to You Automatically

Sign up to receive the latest news and ratings for INFU and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NYSE:INFU) was last updated on 3/11/2025 by MarketBeat.com Staff
From Our Partners